Teriflunomide shows promise for MS treatment in phase III trial

被引：1

|

作者：

Heather Wood

机构：

来源：

Nature Reviews Neurology | 2011年 / 7卷 / 12期

关键词：

D O I：

10.1038/nrneurol.2011.184

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：657 / 657

相关论文

共 50 条

[1] Immunotherapy shows promise in Phase III neuroblastoma trial
不详
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (08) : 604 - 604
[2] Immunotherapy shows promise in Phase III neuroblastoma trial
Nature Reviews Drug Discovery, 2009, 8 : 604 - 604
[3] Novel antiarrhythmic agent shows promise in Phase III trial
Nature Reviews Drug Discovery, 2009, 8 : 266 - 266
[4] Novel antiarrhythmic agent shows promise in Phase III trial
不详
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (04) : 266 - 266
[5] BLYS-targeted antibody shows promise in Phase III SLE trial
Nature Reviews Drug Discovery, 2009, 8 : 688 - 688
[6] BLYS-targeted antibody shows promise in Phase III SLE trial
不详
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (09) : 688 - 688
[7] Entasis antibiotic shows phase III promise
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (12) : 888 - 888
[8] Entasis antibiotic shows phase III promise
Asher Mullard
Nature Reviews Drug Discovery, 2021, 20 : 888 - 888
[9] TRIAL WATCH Integrin antagonist shows promise in MS
Crunkhorn, Sarah
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (03) : 178 - 178
[10] Phase I trial data shows promise for antibody immunotherapy in cancer treatment
Patience, Jonny
EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (06) : 646 - 646

← 1 2 3 4 5 →